Thyroid hormone receptor mediates human MDR1 gene expression-Identification of the response region essential for gene expression

Archives of Biochemistry and Biophysics

Volumn 474, Issue 1, 2008, Pages 82-90

  Kurose, Kouichi ^a   Saeki, Mayumi ^a   Tohkin, Masahiro ^a   Hasegawa, Ryuichi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

ABCB1; P glycoprotein (P gp); Thyroid hormone response element (TRE); Thyroxine (T4); TR; Triiodothyronine (T3)

Indexed keywords

HETERODIMER; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 1; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR;

ARTICLE; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DIMERIZATION; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; P-GLYCOPROTEIN; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 43949100277     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2008.03.020     Document Type: Article

References (37)

1. Lin J.H. Adv. Drug Deliv. Rev. 55 (2003) 53-81
2. Marchetti S., Mazzanti R., Beijnen J.H., and Schellens J.H. Oncologist 12 (2007) 927-941
3. Guengerich F.P. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 1-17
4. Guengerich F.P. Mol. Interv. 3 (2003) 194-204
5. Burk O., Arnold K.A., Geick A., Tegude H., and Eichelbaum M. Biol. Chem. 386 (2005) 503-513
6. Geick A., Eichelbaum M., and Burk O. J. Biol. Chem. 276 (2001) 14581-14587
7. Goodwin B., Hodgson E., D'Costa D.J., Robertson G.R., and Liddle C. Mol. Pharmacol. 62 (2002) 359-365
8. Goodwin B., Hodgson E., and Liddle C. Mol. Pharmacol. 56 (1999) 1329-1339
9. Bonelli J., Haydl H., Hruby K., and Kaik G. Int. J. Clin. Pharmacol. Biopharm. 16 (1978) 302-306
10. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., and Kroemer H.K. J. Clin. Invest. 104 (1999) 147-153
11. Siegmund W., Altmannsberger S., Paneitz A., Hecker U., Zschiesche M., Franke G., Meng W., Warzok R., Schroeder E., Sperker B., Terhaag B., Cascorbi I., and Kroemer H.K. Clin. Pharmacol. Ther. 72 (2002) 256-264
12. Mitin T., Von Moltke L.L., Court M.H., and Greenblatt D.J. Drug Metab. Dispos. 32 (2004) 779-782
13. Flamant F., Baxter J.D., Forrest D., Refetoff S., Samuels H., Scanlan T.S., Vennstrom B., and Samarut J. Pharmacol. Rev. 58 (2006) 705-711
14. Lazar M.A. Endocr. Rev. 14 (1993) 184-193
15. Yen P.M. Physiol. Rev. 81 (2001) 1097-1142
16. Boelaert K., and Franklyn J.A. J. Endocrinol. 187 (2005) 1-15
17. Canaris G.J., Manowitz N.R., Mayor G., and Ridgway E.C. Arch. Intern. Med. 160 (2000) 526-534
18. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., Grimley Evans J., Hasan D.M., Rodgers H., Tunbridge F., et al. Clin. Endocrinol. (Oxf) 43 (1995) 55-68
19. Kurose K., Ikeda S., Koyano S., Tohkin M., Hasegawa R., and Sawada J. Mol. Cell. Biochem. 281 (2006) 35-43
20. Thummel K.E., Brimer C., Yasuda K., Thottassery J., Senn T., Lin Y., Ishizuka H., Kharasch E., Schuetz J., and Schuetz E. Mol. Pharmacol. 60 (2001) 1399-1406
21. Jin M., Shimada T., Shintani M., Yokogawa K., Nomura M., and Miyamoto K. Drug Metab. Pharmacokinet. 20 (2005) 324-330
22. Nishio N., Katsura T., Ashida K., Okuda M., and Inui K. Drug Metab. Dispos. 33 (2005) 1584-1587
23. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., and Vilarem M.J. Biochim. Biophys. Acta 1619 (2003) 243-253
24. Chen Y., Kissling G., Negishi M., and Goldstein J.A. J. Pharmacol. Exp. Ther. 314 (2005) 1125-1133
25. Kodama S., Koike C., Negishi M., and Yamamoto Y. Mol. Cell. Biol. 24 (2004) 7931-7940
26. Sugatani J., Nishitani S., Yamakawa K., Yoshinari K., Sueyoshi T., Negishi M., and Miwa M. Mol. Pharmacol. 67 (2005) 845-855
27. Tien E.S., and Negishi M. Xenobiotica 36 (2006) 1152-1163
28. Synold T.W., Dussault I., and Forman B.M. Nat. Med. 7 (2001) 584-590
29. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., and Kliewer S.A. J. Clin. Invest. 102 (1998) 1016-1023
30. Xie W., Yeuh M.F., Radominska-Pandya A., Saini S.P., Negishi Y., Bottroff B.S., Cabrera G.Y., Tukey R.H., and Evans R.M. Proc. Natl. Acad. Sci. USA 100 (2003) 4150-4155
31. Sugatani J., Kojima H., Ueda A., Kakizaki S., Yoshinari K., Gong Q.H., Owens I.S., Negishi M., and Sueyoshi T. Hepatology 33 (2001) 1232-1238
32. Sankatsing S.U., Beijnen J.H., Schinkel A.H., Lange J.M., and Prins J.M. Antimicrob. Agents Chemother. 48 (2004) 1073-1081
33. Bianco A.C., Salvatore D., Gereben B., Berry M.J., and Larsen P.R. Endocr. Rev. 23 (2002) 38-89
34. Martino E., Bartalena L., Bogazzi F., and Braverman L.E. Endocr. Rev. 22 (2001) 240-254
35. Neves F.A., Cavalieri R.R., Simeoni L.A., Gardner D.G., Baxter J.D., Scharschmidt B.F., Lomri N., and Ribeiro R.C. Endocrinology 143 (2002) 476-483
36. Ribeiro R.C., Cavalieri R.R., Lomri N., Rahmaoui C.M., Baxter J.D., and Scharschmidt B.F. J. Biol. Chem. 271 (1996) 17147-17151
37. Mitchell A.M., Tom M., and Mortimer R.H. J. Endocrinol. 185 (2005) 93-98